{
    "case_number": "CAC-UDRP-103148",
    "time_of_filling": "2020-07-08 09:42:10",
    "domain_names": [
        "buylexaprousa.com"
    ],
    "case_administrator": "  Iveta Špiclová   (Czech Arbitration Court) (Case admin)",
    "complainant": [
        "H. Lundbeck A\/S"
    ],
    "complainant_representative": "Zacco Danmark A\/S",
    "respondent": [
        "Margarita Pilan"
    ],
    "respondent_representative": null,
    "factual_background": "PARTIES' CONTENTIONS:\r\n\r\nCOMPLAINANT:\r\n\r\nFounded in 1915, the Complainant is now is an international pharmaceutical company engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at the disease areas within psychiatry and neurology. The Complainant owns an International Trademark Registration for the word LEXAPRO (registered on March 16, 2002) and also owns the domain name <lexapro.com>. In 2019, the Complaint's revenue was USD 2.56 billion and the Complainant employs approximately 5.800 people worldwide.\r\n\r\nThe disputed domain name <buylexaprousa.com> resolves to a website that appears to contain neutral information on the Complainant’s Lexapro product along with messages claiming that the product is available without a doctor’s prescription (the product is legally only available with such a prescription). The website also contains links to a third-party commercial online pharmacy website titled, “Online Pharmacy”, that claims to offer the sale of the Complainant’s LEXAPRO product as well as pharmaceutical products sold by other companies. The Online Pharmacy website also offers an affiliate program where outside persons can earn fees for directing the traffic of potential customers to the site.\r\n\r\nRESPONDENT:\r\n\r\nThe Respondent has not filed a response or made any other submission in this case.",
    "other_legal_proceedings": "The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.",
    "no_response_filed": "NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).  ",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).  ",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).  ",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Steven M. Levy, Esq."
    ],
    "date_of_panel_decision": "2020-07-31 00:00:00",
    "informal_english_translation": "The Complainant claims ownership of International Trademark Registration No. 778106, registered on March 16, 2002 for the word LEXAPRO in relation to pharmaceutical preparations acting on the central nervous system.",
    "decision_domains": {
        "BUYLEXAPROUSA.COM": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}